Japanese Journal of Clinical Oncology 30:318-321 (2000)
© 2000 Foundation for Promotion of Cancer Research
Cancer Incidence and Incidence Rates in Japan in 1995: Estimates Based on Data from Nine Population-based Cancer Registries
The Research Group for Population-based Cancer Registration in Japan estimated cancer incidence in Japan in 1995 based on data from nine population-based cancer registries: Yamagata, Chiba, Kanagawa, Niigata, Fukui, Osaka, Hiroshima City, Saga and Nagasaki. The methods of estimation and its limitations are explained in Refs 1–3. The number of incidences, crude rates, age-standardized rates and completeness of registration in 1995 are shown in Table 1 and the age-specific number of incidences and the rates are shown in Tables 2 and 3 according to sex and primary site. The number of incidences for 1995 was estimated as 458 700. The time trends of age-standardized incidence rates for major sites in 1975–95 standardized to the world population are shown in Fig. 1 and those standardized to the 1985 Japanese model population are shown in Fig. 2. The leading site in age-standardized incidence rate for females has been the breast since 1993 in Fig. 1. In Fig. 2 the breast became the leading cancer site for females in 1995 for the first time.
|
|
|
|
|
Estimated cancer incidence data in Japan by sex, site, five-year age-group and calendar year during the period 1975–95 are now available on a Web site (http://www.iph.pref.osaka.jp/omc/ocr/) or by correspondence with the principal investigator of the Research Group (Dr A. Oshima).
 |
Acknowledgments |
|---|
 TOP Acknowledgments REFERENCES |
|---|
In 1999 the Research Group conducted the 26th survey on cancer incidence and cancer medical care with the cooperation of the Aichi Cancer Center (Dr T. Kuroishi) and contributions from 12 cancer registries: Yamagata (Dr T. Matsuda,), Chiba (Dr M. Murata,), Kanagawa (Dr N. Okamoto,), Niigata (Dr K. Ogoshi,), Fukui (Dr M. Fujita,), Aichi (Dr M. Inoue), Shiga (Dr H. Shio,), Osaka (Dr A. Oshima,), Hyogo (Dr T. Ishida,), Hiroshima City (Dr K. Mabuchi,), Saga (Dr M. Mori,) and Nagasaki (Dr M. Soda,). The study was supported by a Grant-in-Aid for cancer research from the Japanese Ministry of Health and Welfare (8–2).
|
FOOTNOTES |
|---|
+ *This report was prepared by Wakiko Ajiki, Noriko Kinoshita, Hideaki Tsukuma and Akira Oshima, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanFor reprints and all correspondence: Wakiko Ajiki, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Nakamichi 1–3–3, Higashinari-ku, Osaka 537-8511, Japan. E-mail: xajiki@iph.pref.osaka.jpAbbreviations: ICD-10th, International Classification of Diseases, 10th Revision; DCO/I, proportion of cases with the death certificate only to incident cases; I/D, number of incidences/number of deaths; HV/I, proportion of histologically verified cases to incident cases; CIS, carcinoma in situ
|
REFERENCES |
|---|
|
TOPAcknowledgmentsREFERENCES |
|---|
1 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1988: estimates based on data from ten population-based cancer registries. Jpn J Clin Oncol 1994;24:299–304.
2 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89: re-estimation based on data from eight population-based cancer registries. Jpn J Clin Oncol 1998;28:54–67.
3 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan. In: Tominaga S, Oshima A, editors. Cancer Mortality and Morbidity Statistics Japan and the World – 1999. Monograph on Cancer Research No. 47. Tokyo: Japanese Scientific Societies Press 1999;83–143.
; Received April 3, 2000; accepted May 9, 2000.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Fujiwara, S. Ogawa, M. Motoyama, Y. Takei, S. Machida, A. Taneichi, M. Ohwada, and M. Suzuki Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigations in young women: a report of six cases Hum. Reprod., May 1, 2009; 24(5): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tanaka, Y. Imai, N. Hiramatsu, Y. Ito, K. Imanaka, M. Oshita, T. Hijioka, K. Katayama, I. Yabuuchi, H. Yoshihara, et al. Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003 Ann Intern Med, June 3, 2008; 148(11): 820 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. del Carmen, E. F. Halpern, D. B. Kopans, B. Moy, R. H. Moore, P. E. Goss, and K. S. Hughes Mammographic Breast Density and Race Am. J. Roentgenol., April 1, 2007; 188(4): 1147 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Namiki, S. Ishidoya, T. Tochigi, S. Kawamura, M. Kuwahara, A. Terai, K. Yoshimura, I. Numata, M. Satoh, S. Saito, et al. Health-Related Quality of Life after Intensity Modulated Radiation Therapy for Localized Prostate Cancer: Comparison with Conventional and Conformal Radiotherapy Jpn. J. Clin. Oncol., April 1, 2006; 36(4): 224 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kohno, R. Suzuki, S. Sugie, H. Tsuda, and T. Tanaka Dietary Supplementation with Silymarin Inhibits 3,2'-Dimethyl-4-Aminobiphenyl-Induced Prostate Carcinogenesis in Male F344 Rats Clin. Cancer Res., July 1, 2005; 11(13): 4962 - 4967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Chiba, K. Tokuuye, Y. Matsuzaki, S. Sugahara, Y. Chuganji, K. Kagei, J. Shoda, M. Hata, M. Abei, H. Igaki, et al. Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients Clin. Cancer Res., May 15, 2005; 11(10): 3799 - 3805. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||